drugset / Trial / NCT00335725

Efficacy and Tolerability of Human FSH Versus Recombinant FSH (Follitropin Alpha) in ICSI.

NCT00335725

Phase 3 Completed 151 enrolled IBSA Institut Biochimique SA
RandomizedParallel-groupSingle-blindTreatment

Summary

Purpose of the study is the comparative evaluation of the clinical efficacy and of the general tolerability of two different subcutaneous FSH preparations (Fostimon® IBSA Vs Gonal-F® Serono) when administered in patients undergoing ICSI

Timeline

Start
2003-03
Primary completion
2005-12
Completion
2005-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bravelle Unknown 225 iu Subcutaneous
Comparator Gonal-f Protein / enzyme biologic 225 iu Subcutaneous

Indications